Alexander Dierks and Philipp Schneider Assess Grünhorn's Contribution to Saxony and Germany

On September 15th, Alexander Dierks, a member of the Saxon Parliament and General Secretary of the Saxon Union, and Philipp Schneider, advisor on fundamental issues, visited Grünhorn. During a tour, they discussed Saxony’s contribution to science, pharmacy and medicine in Germany.

Following an in-depth discussion with Grünhorn representatives on current issues related to patient care with medical cannabis and the upcoming legalization, Dierks and Schneider were shown the automated and digitalized workflows of the wholesale and pharmacy operations and also toured the laboratory for the production and analysis of cannabis extracts and capsules. The production of these patient-specific dosage forms highlighted the potential of cannabis therapy, including additional application possibilities and forms of administration beyond inhalation.

The tour underscored how significant cannabinoids can be in medicine for treating chronic pain, epilepsy, multiple sclerosis, and weight loss after chemotherapy. Stefan Fritsch, founder and CEO of the Grünhorn network, and Alexander Dierks emphasized the importance of committed entrepreneurship and responsibility as an employer at the Saxon location.

“We are pleased with the strong interest from the Saxon state government and are very grateful that we were able to demonstrate how dedicated the Grünhorn network is to addressing patient needs as well as to education, information, and youth protection. This was evident in the strong alignment of views and positions between us and Mr. Dierks. We were very pleased that, due to their significant interest, we were able to extend our visit well beyond the planned time for these in-depth discussions,” said Fritsch.

Fritsch continued: “Mr. Dierks and Mr. Schneider support Saxon state chairman, Minister President Michael Kretschmer, in organizing the party and in the parliamentary committees of the Saxon Parliament and the Federal Council. They play a significant role in regional and local political affairs. We are therefore very pleased with the great interest in Grünhorn and are proud to have demonstrated how progressive and motivated Grünhorn is. It also became clear how the analyses of terpenes and cannabinoids contribute to science, pharmacy, and medicine, and how important this contribution from Saxony is for Germany and Europe to provide more patients with better and, above all, de-stigmatized access to medical cannabis in pharmacies.”